Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa massachusetts
  4. stem cell transplants
Show results for
Products
Services

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Massachusetts
Brands

  • seres
  • tafasitamab
  • verax
  • vor
Applications

  • Microbiome Therapeutics for Patients and Physicians

Stem Cell Transplants Equipment Supplied In Usa Massachusetts

4 equipment items found
In MassachusettsAvailable In MassachusettsNear Massachusetts

Seres - Model SER-155 - Investigational, Oral, Rationally Designed, Fermented Microbiome Therapeutic

Seres - Model SER-155 - Investigational, Oral, Rationally Designed, Fermented Microbiome Therapeutic

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-155 is an investigational, oral, rationally designed, fermented microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bacteremia, and graft versus host disease (GvHD) in immunocompromised patients, including patients receiving allogeneic hematopoietic stem cell transplantation ...
CONTACT SUPPLIER

Verax - Cell Therapy PGD Test Kit

Verax - Cell Therapy PGD Test Kit

Manufactured by:Verax Biomedical, Incorporated   based inMarlborough, MASSACHUSETTS (USA)
Stem cells, activated leukocytes and other cellular therapies are another area of obvious applicability for PGD technology as these cells are grown in media that also support bacterial proliferation. As with platelets and red blood cells, current techniques for the detection of contaminating bacteria before ...
CONTACT SUPPLIER

VOR - Model VOR33 (CD33) - Hematopoietic Cells

VOR - Model VOR33 (CD33) - Hematopoietic Cells

by:Vor Biopharma   based inCambridge, MASSACHUSETTS (USA)
VOR33 is our lead eHSC product candidate designed to replace the standard of care in transplant settings. Once the VOR33 cells have engrafted, we believe that patients can be treated with anti-CD33 therapies, such as Mylotarg or VCAR33, with limited on-target toxicity, leading to durable anti-tumor activity and potential cures. In preclinical studies, we have observed that the removal of CD33 ...
CONTACT SUPPLIER

Tafasitamab - Model MOR208 - Humanized FC-Modified CD19 Targeting Immunotherapy

Tafasitamab - Model MOR208 - Humanized FC-Modified CD19 Targeting Immunotherapy

Manufactured by:MorphoSys AG   based inPlanegg, GERMANY
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for the treatment of B cell malignancies, such as non-Hodgkin’s lymphoma (NHL), including diffuse large B cell lymphoma (DLBCL), indolent lymphomas ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT